Skip to main content

Tumor-Associated Antigens: Identification, Characterization, and Clinical Applications

Tumor-Associated Antigens: Identification, Characterization, and Clinical Applications

Olivier Gires (Editor), Barbara Seliger (Editor)

ISBN: 978-3-527-32084-4

Apr 2009, Wiley-Blackwell

383 pages

In Stock

$249.95

Description

The first comprehensive and most recent overview of the topic, this ready reference and handbook reviews current knowledge of TAAs, their subclasses, and pinpoints their application areas in medicine. In addition, it emphasizes target identification procedures, the need for an accurate and thorough analysis of the function of TAAs, and the validation of those in clinical settings. The whole is rounded off with an overview of currently approved therapeutic antibodies.
The result is a must-have for biologists and oncologists in science, clinics and industry.

Buy Both and Save 25%!

This item: Tumor-Associated Antigens: Identification, Characterization, and Clinical Applications

Viral Therapy of Cancer (Hardcover $219.95)

Original Price:$469.90

Purchased together:$352.42

save $117.48

Cannot be combined with any other offers.

Buy Both and Save 25%!

This item: Tumor-Associated Antigens: Identification, Characterization, and Clinical Applications

The Cancer Clock (Paperback $84.00)

Original Price:$333.95

Purchased together:$250.46

save $83.49

Cannot be combined with any other offers.

TUMOUR-ASSOCIATED ANTIGENS (TAAS): SUBCLASSES OF TAAS
T cell Antigens in Cancer (A. Paschen)
Human Tumour Antigens, Immunosurveillance, and Cancer Vaccines (O.J. Finn)
METHODS TO DETECT TAAS
Humoral Antigens in Cancer: Serological Identification Methods, Part I: SEREX (M. Pfreundschuh)
Humoral Antigens in Cancer: Serological Identification Methods, Part II: Proteomex and AMIDA (B. Seliger, O. Gires)
cDNA and Microarray-Based Technologies (F. Marincola, Ena Wang)
Detection and Identification of TAA by SELDI-TOF (F. von Eggeling, C. Melle)
TAAS AND THEIR USEFULNESS
Minor Histocompatibility Antigens and TAAs for Pediatric Cancers (U. Behrends, J. Mautner)
TAAs and their Regulation/Epigenetics (M. Maio)
Cancer-Testis Antigens (CT-antigens) (J.S. Cebon)
Animal Models for TAAs (P. McLaughlin)
Epithelial Cell Adhesion Molecule EpCAM in cancer (CD326) (P.A Baeuerle, G. Riethmüller)
Carcinoembryonic Antigen CEA (W. Zimmermann, R. Kammerer)
Her2/neu and Herceptin (B. Seliger)
Epstein-Barr Virus (EBV) Tumour-Associated Antigens (C. Mancao, W. Hammerschmidt)
Human Papilloma Virus (HPV) Tumour-Associated Antigens (A. Kaufmann)
Circulating TAAs: Biomarkers for Ovarian Cancer Diagnosis (E. Seregni, E. Bombardieri)
CLINICAL APPLICATIONS OF TAAS
Cancer Vaccines (A. Dalgleish)
Peptide Vaccination (D.P. Fairlie)
DNA Vaccination: Human Papilloma Virus (T.C. Wu)
Adoptive T cell transfer (A. Moosmann, A. Krackhardt)

"Overall, the book is very detailed and certainly of use to those working in cancer vaccine and tumour antigen research. It is also readable by those who are not directly in the field but have an interest in cancer and emerging cancer treatments. The general information on techniques provided is also a valuable resource for those considering using these techniques. The book is well produced with few errors." (Australian Biochemist, August 2010)